Clinical trial

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

NCT03882580

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2019-03-01

PhaseN/A

Study timeline

Study start (actual)2019-03-01Date precision: day

Registry last updated2026-09-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cardiovascular Complicationunresolved

Cardiovascular Insufficiencyunresolved

Cardiac Complicationunresolved

Oncologic Complicationsunresolved

Cardiac Insufficiencyunresolved

Metabolic Disorderunresolved

Vascular Disorderunresolved

Cardiac Disorderunresolved

Interventions

Anti-Cancer AgentsDRUG

Sponsors & collaborators

Groupe Hospitalier Pitie-Salpetrierelead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03882580 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.